Literature DB >> 11284129

Uric acid levels in sera from patients with multiple sclerosis.

J Drulović1, I Dujmović, N Stojsavljević, S Mesaros, S Andjelković, D Miljković, V Perić, G Dragutinović, J Marinković, Z Lević, M Mostarica Stojković.   

Abstract

The levels of uric acid (UA), a natural peroxynitrite scavenger, were measured in sera from 240 patients with multiple sclerosis (MS) and 104 sex- and age-matched control patients with other neurological diseases (OND). The mean serum UA concentration was lower in the MS than in the OND group, but the difference did not reach the level of statistical significance (P = 0.068). However, the mean serum UA level from patients with active MS (202.6 + 67.1 mumol/l) was significantly lower than that in inactive MS patients (226.5 + 78.6 mumol/l; P = 0.046) and OND controls (P = 0.007). We found a significant inverse correlation of serum UA concentration with female gender (P = 0.0001), disease activity (P = 0.012) and duration (P = 0.017), and a trend towards an inverse correlation with disability as assessed by EDSS score, which did not reach statistical significance (P = 0.067). Finally, multivariate linear regression analyses showed that UA concentration was independently correlated with gender (P = 0.0001), disease activity (P = 0.014) and duration of the disease (P = 0.043) in MS patients. These findings suggest that serum UA might serve as a possible marker of disease activity in MS. They also provide support to the potential beneficial therapeutic effect of radical-scavenging substances in MS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284129     DOI: 10.1007/s004150170246

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke.

Authors:  Laura Llull; Sergio Amaro; Ángel Chamorro
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis.

Authors:  Stefan Kastenbauer; Bernd C Kieseier; Bernhard F Becker
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

3.  Serum uric acid concentrations are directly associated with the presence of benign multiple sclerosis.

Authors:  Esteban Simental-Mendía; Luis E Simental-Mendía; Fernando Guerrero-Romero
Journal:  Neurol Sci       Date:  2017-06-28       Impact factor: 3.307

4.  Uric acid protects against secondary damage after spinal cord injury.

Authors:  Gwen S Scott; Salvatore Cuzzocrea; Tiziana Genovese; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

5.  Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.

Authors:  May A Beydoun; Jose-Atilio Canas; Gregory A Dore; Hind A Beydoun; Ola S Rostant; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  J Alzheimers Dis       Date:  2016-04-21       Impact factor: 4.472

Review 6.  Recent progress in nanomaterial-based electrochemical and optical sensors for hypoxanthine and xanthine. A review.

Authors:  Muamer Dervisevic; Esma Dervisevic; Mehmet Şenel
Journal:  Mikrochim Acta       Date:  2019-11-06       Impact factor: 5.833

Review 7.  The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders.

Authors:  Roy G Cutler; Simonetta Camandola; Kelli F Malott; Maria A Edelhauser; Mark P Mattson
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

8.  Serum uric acid levels and neuromyelitis optica.

Authors:  Fuhua Peng; Xiufeng Zhong; Xuhui Deng; Wei Qiu; Aimin Wu; Youming Long; Xueqiang Hu; Qing Li; Ying Jiang; Yongqiang Dai
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

9.  Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Maja Milojkovic; Olivera Dunjic; Dragan Stojanov; Dusica Pavlovic
Journal:  Metab Brain Dis       Date:  2013-04-23       Impact factor: 3.584

10.  Uric Acid nephrolithiasis: recent progress and future directions.

Authors:  Tin C Ngo; Dean G Assimos
Journal:  Rev Urol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.